HI
HighMarginJoey
Community Contributor
Member since 2026
Views0Total number of views
Followers0Total number of followers
Comments0Total number of comments
No bio added yet
No link added
Is This Lens Maker Mispriced? A Blind Spot in Plain Sight
RxSight (NASDAQ: RXST), maker of the only cataract lens that can be adjusted post-surgery, could be undervalued by an eye-popping margin More than 70% of RxSight Light Adjustable Lens (LAL) patients reported 20/20 or better vision after receiving the lens. Only 36.3% of non-adjustable lens patients reported the same.Read more
0
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
HI
US$50
82.1% undervalued intrinsic discount
HighMarginJoey's Fair Value
Revenue
19.02% p.a.
Profit Margin
30%
Future PE
20x
Price in 2036
US$105.18